Search

Your search keyword '"sleeping sickness"' showing total 1,138 results

Search Constraints

Start Over You searched for: Descriptor "sleeping sickness" Remove constraint Descriptor: "sleeping sickness"
1,138 results on '"sleeping sickness"'

Search Results

1. Synthesis and in vitro biological activity of chalcone derivatives as potential antiparasitic agents.

3. Investigating trypanosome infection prevalence in three districts of Northern Uganda : a study of trypanosome populations in cattle and humans

4. Mobile Monkeys and Modified Microbes: Medical Experimentation between Metropolitan and Colonial Laboratories, 1880–ca. 1925.

5. Immune Reactions of Vector Insects to Parasites and Pathogens.

6. Exploring the latest breakthroughs in rhodesain inhibitors for African trypanosomiasis.

7. Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease

8. The Janus‑faced functions of Apolipoproteins L in membrane dynamics.

9. 100 years since the publication of the suramin formula.

10. Polyamine Metabolism for Drug Intervention in Trypanosomatids.

11. Epidemiological role of indigenous dogs in the transmission of animal and human African trypanosomiasis in Zambia : a case study of dogs from Mambwe District

12. Analysis of released peptidases and their role in the transmission biology of African trypanosomes

13. Potential applicability of the importation risk index for predicting the risk of rarely imported infectious diseases

14. Population Knowledge and Practices and the Prevalence of Trypanosomes Circulating in Domestic Animals in Three Active Human African Trypanosomiasis Foci in the Republic of Congo

16. Potential applicability of the importation risk index for predicting the risk of rarely imported infectious diseases.

17. Population Knowledge and Practices and the Prevalence of Trypanosomes Circulating in Domestic Animals in Three Active Human African Trypanosomiasis Foci in the Republic of Congo.

18. Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies.

19. The synthesis of novel fluorinated heterocycles and their antitrypanosomal activity

20. Structural Modelling of Platelet Activating Factor Acetyl Hydrolase in Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei: Implications on Therapeutics for Leishmaniasis, Chagas Disease, and Sleeping Sickness

21. Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options.

22. Effects of Synthetic Ligustrazine-Based Chalcone Derivatives on Trypanosoma brucei brucei and Leishmania spp. Promastigotes.

23. Antitrypanosomal activity of Argemone mexicana extract and fractions in the animal model of Trypanosoma brucei brucei infection

30. Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates.

31. Phytochemical Screening, GC-MS Analysis, and Evaluating In Vivo Antitrypanosomal Effects of a Methanolic Extract of Garcinia kola Nuts on Rats.

32. Polyamine Metabolism for Drug Intervention in Trypanosomatids

33. A doença de Chagas: repercussões de uma descoberta científica brasileira em Portugal, 1909-1924

34. Re-screening and preliminary in vitro evaluation of resorcinol based Hsp90 inhibitors for potential protocidal activity.

35. Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership.

36. Plasma Neuron-Specific Enolase is not a reliable biomarker for staging Trypanosoma brucei rhodesiense sleeping sickness patients

37. Tackling Sleeping Sickness: Current and Promising Therapeutics and Treatment Strategies

38. Activity of the genus Zanthoxylum against diseases caused by protozoa: A systematic review

39. 2-(Nitroaryl)-5-Substituted-1,3,4-Thiadiazole Derivatives with Antiprotozoal Activities: In Vitro and In Vivo Study.

40. The History of the ABC Proteins in Human Trypanosomiasis Pathogens.

41. Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease.

44. Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo

45. Structural insights into innate immunity against African trypanosomes

46. Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options

47. Effects of Synthetic Ligustrazine-Based Chalcone Derivatives on Trypanosoma brucei brucei and Leishmania spp. Promastigotes

48. Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.

49. Wilful Blindness: Sleeping Sickness and Onchocerciasis in Colonial Northern Ghana, 1909–1957.

50. Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based Therapy.

Catalog

Books, media, physical & digital resources